Cipla's Financial Leap: Record Profits in Q3 2024
Cipla, a leading pharmaceutical company, reported a 48.73% increase in its consolidated net profit for the third quarter of 2024, reaching Rs 1,570.51 crore. This marks a significant rise from Rs 1,055.9 crore in the same period last year, with revenue climbing to Rs 7,072.97 crore.
![Cipla's Financial Leap: Record Profits in Q3 2024](https://devdiscourse.blob.core.windows.net/aiimagegallery/26_07_2024_10_59_32_6818819.png)
- Country:
- India
In a notable financial performance, pharmaceutical giant Cipla has reported a 48.73% increase in its consolidated net profit for the third quarter ending December 31, 2024, marking a significant rise to Rs 1,570.51 crore.
Comparatively, the company recorded a net profit of Rs 1,055.9 crore in the same period of the previous fiscal year, showcasing a substantial improvement in financial outcomes.
Additionally, Cipla's revenue from operations also demonstrated a positive trajectory, climbing to Rs 7,072.97 crore compared to Rs 6,603.81 crore last year. On the BSE, Cipla's shares ascended 4.28%, trading at Rs 1,455.70.
(With inputs from agencies.)
Advertisement
ALSO READ
Indian Stock Market Boom: Household Participation Soars
Global Tensions Rattle Stock Markets: Vodafone and Diageo Drop Amid Trade Concerns
Govt Issues Uniform Code for Ethical Pharmaceutical Marketing Practices 2024
Women and Youth on the Rise in India's Stock Market Scene
Pound Gains and Rate Decisions Shape UK Stock Market Trends